FINWIRES · TerminalLIVE
FINWIRES

Travere Therapeutics Insider Sold Shares Worth $360,000, According to a Recent SEC Filing

作者

-- Jeffrey A Meckler, Director, on May 04, 2026, sold 8,000 shares in Travere Therapeutics (TVTX) for $360,000. Following the Form 4 filing with the SEC, Meckler has control over a total of 87,500 common shares of the company, with 87,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1438533/000150691626000001/xslF345X05/form4-05062026_080516.xml

相關文章